6 Min Read
HAVANA (Reuters) - As Latin American nations test experimental coronavirus vaccines from across the globe and economic heavyweights such as Brazil and Mexico jockey for supply deals with major drugmakers, Communist-run Cuba already has two of its own vaccines in clinical trials.
FILE PHOTO: Small bottles labelled with Vaccine stickers stand near a medical syringe in front of displayed Coronavirus COVID-19 words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration
Should its efforts succeed, the Caribbean island could become an important supplier to neighboring countries that might otherwise struggle to access vaccine supply as wealthy Western nations rush to secure doses, regional experts said.
Feb 3, 2021 11:51 AM EDT
GENEVA (AP) A U.N.-backed program to deploy COVID-19 vaccines to the neediest people worldwide, especially in poor countries, announced plans Wednesday for an initial distribution of 100 million doses by the end of March and 200 million more by July hoping to catch up with rich countries that are already deep into rollouts.
Leaders of the COVAX Facility, which seeks a fair distribution of vaccines at a time of short supply, said nearly all of the doses expected for the initial-phase rollout are to come from British-Swedish drugmaker AstraZeneca and its partner, the Serum Institute of India.
SHARE
The Covax initiative, which seeks to ensure equitable global access to Covid-19 vaccines, hopes to deliver a dose to 3.3 per cent of the populations of 145 countries by the end of the first half of 2021.
An interim report by the UN-backed facility said 337 million doses should be enough to protect the most vulnerable groups, such as health workers, in countries that face difficulties in obtaining vaccines.
It is expected that more than 100 million doses will be delivered by the end of March.
Almost all of the distribution in the first half of the year will come from UK pharmaceutical company AstraZeneca and its Indian partner, the Serum Institute of India.
Colombia is one of the 18 countries set to receive the Pfizer vaccine Jamey Keaten, Associated Press 03 February, 2021 15:22
A UN-backed programme to deploy Covid-19 vaccines to the neediest people worldwide has announced plans for an initial distribution of some 100 million doses by the end of March and more than 200 million more by the end of June.
The Covax Facility, which is seeking the fair distribution of vaccines at a time of short supplies, said that nearly all of the doses expected for the first phase would come from British/Swedish drugmaker AstraZeneca and its partner, the Serum Institute of India.
Dr Seth Berkley, chief executive of Gavi, the Vaccine Alliance, said Covax planned for the initial distribution of 336 million doses of the vaccine, which AstraZeneca developed with Oxford University, through June to dozens of countries.
UN-backed program seeks rollout of 100M vaccine doses in Q1 washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.